PROKIDNEY CORP.
Biotechnology company developing a cell therapy platform for Chronic Kidney Disease.
PROK | US
Overview
Corporate Details
- ISIN(s):
- KYG8253W1096 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2000 FRONTIS PLAZA BLVD., 27103 WINSTON-SALEM
- Website:
- https://prokidney.com/
- Sector:
- Manufacturing
Description
ProKidney Corp. is a late clinical-stage biotechnology company developing a proprietary, first-in-class cell therapy platform for the treatment of advanced Chronic Kidney Disease (CKD). Its lead investigational candidate, rilparencel, is an autologous therapy derived from a patient's own kidney cells, which are obtained via a standard biopsy. The therapeutic approach aims to preserve remaining kidney function. Rilparencel is being evaluated for its potential to slow disease progression, with the goal of delaying or eliminating the need for dialysis in patients with limited treatment options.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PROKIDNEY CORP. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PROKIDNEY CORP.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PROKIDNEY CORP. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
